Astellas Pharma (United States)
Astellas Pharma Inc. is a Japanese multinational pharmaceutical company, formed on 1 April 2005 from the merger of Yamanouchi Pharmaceutical Co., Ltd. and Fujisawa Pharmaceutical Co., Ltd.. Astellas is a member of the Mitsubishi UFJ Financial Group keiretsu. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Astellas Pharma (United States), United States, covering academic research published from 2005 to 2024. Read More.
Open Access Percentage
58%
Total
Publications
1.7K
Total Open
Publications
982
Total
Citations
49K
Open Access
Percentage
58%
Total
Publications
1.7K
Total Open
Publications
982
Total
Citations
49K
Breakdown
Publisher Open
24%
Both
28%
Other Platform Open
6%
Closed
42%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 23%
208
Hybrid 53%
470
No Guarantees 24%
212
Other Platform Open
Domain 91%
517
Institution 15%
87
Public 8%
48
Other Internet 8%
44
Preprint 1%
3
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 515 |
Europe PMC | Domain | 231 |
DOI | Other Internet | 59 |
Figshare | Public | 35 |
Semantic Scholar | Public | 31 |
University of California - eScholarship University of California | Institution | 15 |
University of Southern Denmark - University of Southern Denmark Research Portal | Institution | 14 |
California Digital Library - eScholarship | Other Internet | 14 |
University College London - UCL Discovery | Institution | 10 |
Taylor and Francis Group - Dove Medical Press | Other Internet | 9 |